Pappas, P. G.; Rotstein, C. M.; Betts, R. F.; Nucci, M; Talwar, D; De Waele, J. J.; Vazquez, J. A.; Dupont, B. F.; Horn, D. L. (2007). “Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis”. Clinical Infectious Diseases. 45 (7): 883–93. doi:10.1086/520980. PMID17806055.
Pettengell, K; Mynhardt, J; Kluyts, T; Lau, W; Facklam, D; Buell, D; FK463 South African Study Group (2004). “Successful treatment of oesophageal candidiasis by micafungin: A novel systemic antifungal agent”. Alimentary Pharmacology and Therapeutics. 20 (4): 475–81. doi:10.1111/j.1365-2036.2004.02083.x. PMID15298643.
Kohno, S; Masaoka, T; Yamaguchi, H; Mori, T; Urabe, A; Ito, A; Niki, Y; Ikemoto, H (2004). “A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan”. Scandinavian Journal of Infectious Diseases. 36 (5): 372–9. doi:10.1080/00365540410020406. PMID15287383.
Hashimoto, S (2009). “Micafungin: A sulfated echinocandin”. The Journal of Antibiotics. 62 (1): 27–35. doi:10.1038/ja.2008.3. PMID19132058.
Fujie, Akihiko (2007). “Discovery of micafungin (FK463): A novel antifungal drug derived from a natural product lead”. Pure and Applied Chemistry. 79 (4): 603–614. doi:10.1351/pac200779040603.
nih.gov
pubmed.ncbi.nlm.nih.gov
Pappas, P. G.; Rotstein, C. M.; Betts, R. F.; Nucci, M; Talwar, D; De Waele, J. J.; Vazquez, J. A.; Dupont, B. F.; Horn, D. L. (2007). “Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis”. Clinical Infectious Diseases. 45 (7): 883–93. doi:10.1086/520980. PMID17806055.
Pettengell, K; Mynhardt, J; Kluyts, T; Lau, W; Facklam, D; Buell, D; FK463 South African Study Group (2004). “Successful treatment of oesophageal candidiasis by micafungin: A novel systemic antifungal agent”. Alimentary Pharmacology and Therapeutics. 20 (4): 475–81. doi:10.1111/j.1365-2036.2004.02083.x. PMID15298643.